{"id":195875,"date":"2026-08-11T10:35:51","date_gmt":"2026-08-11T05:05:51","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=195875"},"modified":"2026-08-11T10:35:51","modified_gmt":"2026-08-11T05:05:51","slug":"glenmark-life-sciences-ltd-share-price-52-week-high-2026-08-11","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/glenmark-life-sciences-ltd-share-price-52-week-high-2026-08-11\/","title":{"rendered":"Glenmark Life Sciences Ltd. (ALIVUS) Share Price Hits Fresh 52-Week High"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/alivus\/glenmark-life-sciences-ltd-share-price-today\">Glenmark Life Sciences Ltd.<\/a> traded at Rs 1,386.75, up 0.95% today, after hitting a fresh 52-week high of Rs 1,415.90. Market capitalisation stood at Rs 16,865.73 crore.<\/p>\n<p style=\"margin-top:0!important;\">Glenmark Life Sciences Ltd. Share Price was at Rs 1,386.75 on 11 August 2026, up Rs 13 or 0.95% from the previous close of Rs 1,373.75, after the stock touched a fresh 52-week high of Rs 1,415.90 in intraday trade. The company\u2019s market capitalisation stood at Rs 16,865.73 crore, placing it among the larger names in the supplied Healthcare sector universe.<\/p>\n<p>For investors searching Glenmark Life Sciences Ltd. Share Price Today, the key verified takeaway is straightforward: the stock entered the 52-week high list, traded in a Rs 1,381.50 to Rs 1,415.90 intraday band, and generated turnover of Rs 0.64 crore on volume of 4,643 shares. The supplied data confirms the price event, but it does not establish a company-specific catalyst behind today\u2019s move.<\/p>\n<p>That still makes the stock relevant in Stock Market Today and Share Market Today screens because a fresh yearly high often draws attention to valuation, profitability and sector position. In this Univest stock analysis, the next points to monitor are price behaviour around the new 52-week peak, the stock\u2019s valuation versus Healthcare benchmarks, and how its return ratios compare with peers.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Glenmark_Life_Sciences_Ltd_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Glenmark Life Sciences Ltd. Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,386.75<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,373.75<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 13 (+0.95%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,384.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Fresh 52-Week High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,415.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,381.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4,643<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.64 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 16,865.73 crore<\/td>\n<\/tr>\n<\/table>\n<p>Glenmark Life Sciences Ltd. (ALIVUS) traded at Rs 1,386.75. versus the previous close of Rs 1,373.75, a rise of 0.95%. The stock opened at Rs 1,384.4, reached Rs 1,415.9, touched Rs 1,381.5. Reported volume was 4,643.<\/p>\n<p>Glenmark Life Sciences Ltd. Share Price Today reflects a session in which the stock moved above its earlier one-year range and printed a fresh 52-week high of Rs 1,415.90. The day\u2019s data shows a modest gain from the previous close, a firm open, and intraday participation that kept the stock on investor watchlists.<\/p>\n<p>The stock opened at Rs 1,384.40, slightly above the previous close of Rs 1,373.75, and later advanced to Rs 1,415.90, which now stands as the new 52-week high. By the time of the article event, Glenmark Life Sciences Ltd. Share Price was at Rs 1,386.75, still holding onto a gain of Rs 13 for the day, or 0.95%.<\/p>\n<p>The intraday low was Rs 1,381.50, which means the trading band for the session was relatively contained even as the stock registered a new yearly high. That is worth noting because it suggests the move to the 52-week peak occurred without an extreme gap between the day\u2019s low and high. In Market News terms, this was a clean price action event rather than a highly erratic spike.<\/p>\n<p>Turnover stood at Rs 0.64 crore and current volume at 4,643 shares. For traders and long-term investors alike, Glenmark Life Sciences Ltd. Share Price Live action is therefore notable less for a sharp daily percentage surge and more for the fact that the stock has moved into a fresh one-year high zone. That naturally shifts the discussion from intraday movement to whether fundamentals support continued investor attention.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Glenmark_Life_Sciences_Ltd_ALIVUS_Fundamental_Analysis\"><\/span><strong>Glenmark Life Sciences Ltd. (ALIVUS) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 16,865.73 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">40.09x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">9.77x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.21%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.35%<\/td>\n<\/tr>\n<\/table>\n<p>Glenmark Life Sciences Ltd. was valued at a P\/E ratio of 40.09x, a P\/B ratio of 9.77x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of 28.21% and ROCE of 26.35%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">40.09x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.84x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">76.55x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 3,396.3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">9.77x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.93x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.21%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.77%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 16,865.73 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 142.3 crore<\/td>\n<\/tr>\n<\/table>\n<p>Glenmark Life Sciences Ltd. (ALIVUS) is classified under sector: Healthcare.<\/p>\n<p>Glenmark Life Sciences Ltd. (ALIVUS) has a P\/E ratio of 40.09x, which is above the benchmark median of 20.84x, a difference of +92.37%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Glenmark Life Sciences Ltd. (ALIVUS) has a ROE of 28.21%, which is above the benchmark median of 10.77%, a difference of +161.93%. Glenmark Life Sciences Ltd. (ALIVUS) has a ROCE of 26.35%, which is above the benchmark median of 13.35%, a difference of +97.38%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\"><strong>Kwality Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KPL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,707.2<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">40.09<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.77<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,631.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">66.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.59<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dragarwq\/dr-agarwals-eye-hospital-ltd-share-price-today\"><strong>Dr Agarwals Eye Hospital Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DRAGARWQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,601.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.04<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.92<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/saiparent\/sai-parenteral-s-ltd-share-price-today\"><strong>Sai Parenteral&#39;s Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SAIPARENT<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,513.58<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">181.97<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.36<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.97<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/nglfine\/ngl-fine-chem-ltd-share-price-today\"><strong>NGL Fine-Chem Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">NGLFINE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,118.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">44.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">27.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.91<\/td>\n<\/tr>\n<\/table>\n<p>Glenmark Life Sciences Ltd. (ALIVUS) has a P\/E ratio of 40.09x compared with the displayed peer median of 44.48x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 28.21% compares with a peer median of 18.65% across the companies shown in the table. ROCE stood at 26.35% versus the displayed peer median of 22.17%, providing a capital-efficiency comparison. Glenmark Life Sciences Ltd. (ALIVUS) has a market capitalisation of Rs 16,865.73 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Glenmark_Life_Sciences_Ltd\"><\/span><strong>Why Investors Are Watching Glenmark Life Sciences Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Investors are watching the stock because today\u2019s move combines a fresh 52-week high with valuation and profitability numbers that stand out against both sector benchmarks and listed peers. The verified dataset highlights price action, relative scale and return ratios as the main reasons Glenmark Life Sciences Ltd. Latest News is being tracked.<\/p>\n<ul>\n<li><strong>Fresh one-year high:<\/strong> the stock touched Rs 1,415.90, its new 52-week peak.<\/li>\n<li><strong>Positive daily move:<\/strong> Glenmark Life Sciences Ltd. Share Price Today was up Rs 13, or 0.95%, versus the previous close.<\/li>\n<li><strong>Large market value:<\/strong> market capitalisation stood at Rs 16,865.73 crore.<\/li>\n<li><strong>Strong profitability metrics:<\/strong> ROE was 28.21% and ROCE was 26.35%.<\/li>\n<li><strong>Premium valuation:<\/strong> P\/E at 40.09 and P\/B at 9.77 sit above sector medians.<\/li>\n<li><strong>Sector standing:<\/strong> the company\u2019s market cap is far above the supplied Healthcare benchmark median and average.<\/li>\n<li><strong>Peer position:<\/strong> return ratios compare favourably with most supplied peers, while market cap is the highest in the peer set.<\/li>\n<\/ul>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Glenmark_Life_Sciences_Ltd\"><\/span><strong>About Glenmark Life Sciences Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Glenmark Life Sciences Ltd. (ALIVUS) is a listed company being tracked in the Healthcare sector. In today\u2019s Glenmark Life Sciences Ltd. Company News flow, the stock has entered focus because it recorded a fresh 52-week high and moved into the set of closely watched momentum names in the Indian Stock Market.<\/p>\n<p>The supplied dataset identifies the company through its listed symbol ALIVUS and places it within the Healthcare space used for the benchmark and peer comparison in this article. While the event data here is centred on market behaviour rather than a broader company profile, investors following Glenmark Life Sciences Ltd. NSE and Glenmark Life Sciences Ltd. BSE search intent are currently watching the stock for its price action, market capitalisation, valuation ratios and return metrics. On Univest, those figures provide the basis for a fact-led market update without extending beyond the verified data.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Glenmark_Life_Sciences_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Glenmark Life Sciences Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/alivus\/glenmark-life-sciences-ltd-share-price-today\">Glenmark Life Sciences Ltd. (ALIVUS) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Univest helps users track Glenmark Life Sciences Ltd. Share Price through live market updates, 52-week levels, valuation ratios, peer comparison and sector context. For investors following Glenmark Life Sciences Ltd. Share Price Live, Glenmark Life Sciences Ltd. Shareholding Pattern, Glenmark Life Sciences Ltd. Market Cap and broader Stock Updates, today\u2019s fresh 52-week high makes the stock worth monitoring on a data-first basis.<\/p>\n<p>On Univest, users can follow Glenmark Life Sciences Ltd. Share Price Today alongside market capitalisation, P\/E, P\/B, ROE, ROCE and the stock\u2019s position against Healthcare benchmarks. That is especially useful when a stock appears in 52 Week High screens and investors want a single view of price action, fundamental analysis and peer positioning without relying on speculation.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_latest_Glenmark_Life_Sciences_Ltd_Share_Price_Today\"><\/span><strong>What is the latest Glenmark Life Sciences Ltd. Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Glenmark Life Sciences Ltd. Share Price Today was Rs 1,386.75 at the time of the event. The stock was up Rs 13, or 0.95%, from the previous close of Rs 1,373.75 after touching a fresh 52-week high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_fresh_52-week_high_for_Glenmark_Life_Sciences_Ltd\"><\/span><strong>What was the fresh 52-week high for Glenmark Life Sciences Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock touched a fresh 52-week high of Rs 1,415.90 in intraday trade. That one-year high is the key verified event behind today\u2019s market attention, even though the supplied data does not identify a company-specific trigger.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_Glenmark_Life_Sciences_Ltd_gain_today\"><\/span><strong>How much did Glenmark Life Sciences Ltd. gain today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Glenmark Life Sciences Ltd. rose by Rs 13 on the day, which translates into a gain of 0.95%. The move came after a previous close of Rs 1,373.75 and kept the stock in positive territory near its yearly high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_todays_price_action_show_for_Glenmark_Life_Sciences_Ltd\"><\/span><strong>What does today\u2019s price action show for Glenmark Life Sciences Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock opened at Rs 1,384.40, moved between Rs 1,381.50 and Rs 1,415.90, and traded at Rs 1,386.75 around the event time. That sequence shows a firm open, a fresh 52-week peak and a still-positive session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Glenmark_Life_Sciences_Ltd\"><\/span><strong>What is the market capitalisation of Glenmark Life Sciences Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Glenmark Life Sciences Ltd. had a market capitalisation of Rs 16,865.73 crore in the supplied data. That is far above the Healthcare sector benchmark median of Rs 142.30 crore and average of Rs 472.15 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Glenmark_Life_Sciences_Ltd_expensive_based_on_PE_and_PB\"><\/span><strong>Is Glenmark Life Sciences Ltd. expensive based on P\/E and P\/B?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock traded at a P\/E of 40.09 and a P\/B of 9.77. Those figures are above the Healthcare sector median P\/E of 20.84 and median P\/B of 1.93, indicating a premium to benchmark medians.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_strong_are_Glenmark_Life_Sciences_Ltds_profitability_ratios\"><\/span><strong>How strong are Glenmark Life Sciences Ltd.&#39;s profitability ratios?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied profitability ratios are strong relative to the benchmark set. ROE stands at 28.21% and ROCE at 26.35%, both above the Healthcare sector median of 10.77% ROE and 13.35% ROCE.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Glenmark_Life_Sciences_Ltd_compare_with_its_peers\"><\/span><strong>How does Glenmark Life Sciences Ltd. compare with its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> In the supplied peer set, Glenmark Life Sciences Ltd. has the highest market capitalisation at Rs 16,865.73 crore. Its ROE and ROCE are stronger than most peers, while valuation is lower than Beta Drugs and Sai Parenteral&#39;s on P\/E.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_trading_volume_and_turnover_in_Glenmark_Life_Sciences_Ltd_today\"><\/span><strong>What was the trading volume and turnover in Glenmark Life Sciences Ltd. today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock recorded current volume of 4,643 shares and turnover of Rs 0.64 crore in the supplied session data. Those figures confirm active trading interest as the stock moved to a fresh 52-week high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Glenmark_Life_Sciences_Ltd_in_the_news_today\"><\/span><strong>Why is Glenmark Life Sciences Ltd. in the news today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Glenmark Life Sciences Ltd. is in the news because it touched a fresh 52-week high of Rs 1,415.90. Investors are also watching its Rs 16,865.73 crore market cap and profitability metrics of 28.21% ROE and 26.35% ROCE.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Glenmark Life Sciences Ltd. Share Price hits a new 52-week high at Rs 1,386.75. marking a 0.95% rise today. Market cap stands at Rs 16,865.73 crore.<\/p>\n","protected":false},"author":29,"featured_media":195873,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-195875","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["195873"],"rank_math_title":["Glenmark Life Sciences Ltd. Share Price at 52-Week High"],"rank_math_description":["Glenmark Life Sciences Ltd. Share Price touched a fresh 52-week high. See today's move, market cap, valuation and Healthcare sector comparison."],"rank_math_focus_keyword":["Glenmark Life Sciences Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Glenmark_Life_Sciences_Ltd_ALIVUS_Share_Price_Hits_Fresh_52_Week_High_bullish-3.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/195875","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=195875"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/195875\/revisions"}],"predecessor-version":[{"id":195876,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/195875\/revisions\/195876"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/195873"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=195875"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=195875"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=195875"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}